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Abstract
Intravenous catheterization is a widely used invasive procedure, with applications in 
both ambulatory and hospital settings. Due to its inherently invasive nature, intravenous 
(IV) therapy is associated with a number of potential complications, many of which are 
directly relevant to patient safety (PS). PIV-related morbidity may be due to mechanical 
or nonmechanical factors. The most frequent nonmechanical peripheral venous cath-
eterization adverse events (PVCAEs) include insertion site pain, phlebitis, hematoma 
formation, and infusate extravasation. The most common mechanical PVCAE is catheter 
obstruction/occlusion and dislodgement. Significant complications can also occur with 
the administration of incorrect type or wrong amount of IV fluids. Moreover, simulta-
neous infusion of incompatible medications can result in infusate precipitation. Finally, 
less frequent but significant complications have been reported, including bloodstream 
and local infections, air embolization, nerve damage, arterial puncture, skin necrosis 
associated with vasopressor infusions, and limb-threatening forgotten tourniquet events. 
Taken together, the above complications can lead to substantial patient discomfort, 
unnecessary or prolonged hospitalization, increased costs, and additional downstream 
morbidity. Efforts to prevent PVCAEs and improve patient outcomes should involve 
thorough provider education, clinical vigilance by all involved healthcare providers, 
health service level strategies, as well as the proactive participation of all stakeholders, 
including patients and their families.
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1. Introduction
Intravenous therapy (IVT) is a treatment modality based on infusing various compatible flu-
ids (e.g., solutions, medications, blood, or blood products) directly into a vein [1–3]. Modern 
clinical efforts at IVT began in the early seventeenth century, but due to complications and 
generally poor results, the practice was largely abandoned until the nineteenth-century chol-
era epidemic [4, 5]. Early publications on IVT date back to the 1880s, when Dr. Thomas Latta 
described its use during the cholera epidemic in Britain [4, 6]. The standard IV use of saline 
solutions did not begin until the early 1900s. Further advances in IVT occurred in the 1930s, 
but this modality was not widely available until the 1950s [3, 7, 8]. It was not until the twenti-
eth century, after the two world wars, and the discovery of blood group types and pyrogens, 
that clinical use of IVT gained more traction [5, 9]. The introduction of plastic bags and IV 
catheters in the late twentieth century, combined with modern infection control practices, 
resulted in IVT becoming a widespread and lifesaving therapeutic option [5, 10]. Intravenous 
administration of fluids in the emergency setting (e.g., trauma, sepsis) can be a lifesaving 
maneuver and represents the primary method of ensuring adequate intravascular fluid status 
for patients who are unable to tolerate enteral nutrition [11, 12]. It is estimated that hundreds 
of millions of PIV catheterizations are performed worldwide each year [13]. The vast majority 
of these procedures are conducted by nursing staff, with the remainder performed by spe-
cialty teams [14]. Of note, approximately 80% of all hospitalized patients receive IVT [15, 16]. 
At the same time, the frequency of “idle catheters” (e.g., with no active medication or fluid 
infusion) can be as high as 16%, with approximately 12% reporting at least one sign/symptom 
of phlebitis [14]. The results of a more recent retrospective cohort study of 3829 patients by 
Limm et al. showed that 50% of PIVCs inserted in the ED went unused. Of the 43% of patients 
with idle catheters then admitted to the hospital wards, these continued to be unused 72 h 
later [17]. There is an increasing awareness (and concern) of the possible morbidity, including 
life and limb injury, associated with the highly prevalent usage of IVT [18]. The purpose of 
this chapter is to provide a comprehensive overview of all major complications and patient 
safety considerations associated with PIVs and IVT in the adult population. In addition, we 
provide an illustrative case of a “forgotten tourniquet” to illustrate the importance of patient 
safety measures in this important area of clinical care.
2. Types of venous access
Safe, dependable venous access for infusions is a critical part of patient care. There are two 
primary types—peripheral and central venous access. The type of access is selected based on 
the anticipated duration of IVT, the type of medication or solution to be infused, and patient-
specific considerations [19, 20]. The focus of this chapter, the PIV catheter, is a short intrave-
nous catheter placed via venipuncture into a peripheral vein, while central venous catheters 
are inserted into large veins of the central circulation system (e.g., subclavian, jugular, and 
femoral). Performed an estimated 150–200 million times annually in North America alone, 
the impact of PIVs is difficult to comprehend [21]. Moreover, up to 8–23% of patients in the 
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emergency department experience difficult PIV placement (e.g., multiple attempts, infiltra-
tion, and other placement-related complications). These patients are more likely to require 
central venous access, which includes significantly higher associated morbidity. Ultrasound-
guided PIV catheterization can reduce the need for central venous access, thus potentially 
reducing morbidity [21]. Not only does the ultrasound-guided PIV access decrease the reli-
ance on central venous access, but it also decreases the overall time, number of attempts, and 
needle redirections compared to more traditional placement methods [22, 23]. While PIVs are 
the preferred access mode for short-term IVT, central venous access is utilized for long-term 
administration of medications or parenteral nutrition [23–27]. At times, when PIV access can-
not be established or is quantitatively insufficient for the delivery of desired volume or fluid 
type, central venous access may be the only viable option to consider [15, 28].
3. Indications and common anatomic sites of peripheral intravenous 
catheterization
PIV catheterization is indicated for short-term use across a broad range of clinical scenarios, 
including administration of IV fluids, drugs, blood/blood products, dyes, and contrast media 
[28, 29]. Several factors must be considered when selecting a site for PIV catheterization. 
Although common sites of insertion are generally described as the lower arm and the dorsum 
of the hand, superficial veins of the lower limbs can also be used for cannulation in certain 
clinical situations [30]. The direct and indirect risks of complications can be curtailed by a 
more thorough assessment of the vascular anatomy prior to choosing the optimal site, based 
on both infusion- and patient-related factors [31–35]. Carr et al. reported that the antecubital 
fossa (ACF), the most common insertion site cannulated in their study of 252 ED patients, was 
associated with the best rates of insertion success (54.78%), but a secondary analysis revealed 
that these successfully inserted PIVCs repeatedly failed to last for the intended 3-day dwell 
time after transfer from the ED to the general hospital units [31]. In a project to reduce infusion 
pump alarms, Matocha [34] reported that occlusion alarms (60%) represented the highest vol-
ume of alarms in a medical oncology unit. After intervention, occlusion alarms were reduced 
by 17% but still represented the highest volume of alarms, which the author hypothesized 
might be associated with the majority of catheter placements in the antecubital area due to flex-
ion at the site. Decreasing antecubital area placement in the first place through staff education 
regarding vascular access planning and insertion competency was suggested as one way of 
reducing occlusion alarms. Alarm frequency may interfere with patients’ sleep, cause unneces-
sary anxiety, and potentially negatively impact healing [32, 33]. It is imperative to consider the 
clinical status of the patient carefully before selecting the site. Such assessment should consider 
the general condition of the veins, tortuosity, locations of valves, bifurcations [36], the size of 
cannula, type of drug to be administered, infusion rate, and duration of the intended IVT [30]. 
Intravenous cannula gauge and site of placement are critical factors in defining the success and 
longevity of PIV cannula [37]. Of note, larger gauge (P = 0.0002, RR = 1.17, 95% CI 1.08–1.27) 
and forearm placement (P = 0.005, RR = 0.7, 95% CI 0.55–0.9) are among the strongest predictors 
of longer functional cannula life [38]. Evidence demonstrates the usefulness of multimodality 
methodology in improving in first-time insertion success rate [2, 37].
Dangers of Peripheral Intravenous Catheterization: The Forgotten Tourniquet and Other Patient…
http://dx.doi.org/10.5772/intechopen.83854
117
Overall, success rates for PIV placement range between 61 and 90%, with successful insertions 
being associated with visible or palpable veins, providers with greater procedural volumes, and 
inserters who were able to predict that placement would be successful [39]. Level of successful 
venous access also appears to be associated with various patient factors (e.g., age, body mass 
index, etc.) [40]. Difficult venous access is characterized by non-visible and non-palpable veins 
for various reasons, including chronic disease, history of intravenous drug use, history of che-
motherapy, obesity, or malnourishment [41]. In addition to excellent technical skill and clinical 
knowledge, various vein visualization devices and ultrasound-based approaches can be helpful in 
facilitating successful PIV insertion [36]. Such devices include infrared vein visualizers and ultra-
sound; however, operator experience is required for optimal outcomes and success rates [42]. The 
ability to leverage adjunctive devices to identify more veins can lead to greater placement and suc-
cessful and speedier cannulations [40]. In addition, assistive devices may help reduce the number 
of insertion attempts and diminish complications such as unintended arterial puncture [43, 44].
4. Clinical vignette
A 49-year-old female with type 2 diabetes mellitus and morbid obesity underwent an abdomi-
noplasty due to recurrent lower abdominal cellulitis. Following a series of failed PIV placement 
attempts in the left forearm, venous access was established on the dorsum of left hand with an 
18G cannula. This PIV was then used during the induction of anesthesia, without any apparent 
problems. The complex operation took approximately 5 h to complete. During this time, fluid 
replacements were given intravenously. During the procedure, there was no evidence of left 
upper extremity swelling, color, or temperature change. The point of insertion of the PIV can-
nula appeared unremarkable when the patient arrived in the postanesthesia care unit (PACU).
Within 4 h, however, the patient reported severe pain in her left hand. This pain persisted 
despite escalating doses of analgesics. There was a mild but visible swelling in the left hand 
as compared to the right side, along with decreased capillary refill and distal paresthesia. 
When the patient's surgeon came to examine the patient, he exposed the entire left upper 
extremity and discovered an intravenous tourniquet still in place, hiding behind the hospital 
gown sleeve. The tourniquet was immediately removed, but it was too late to reverse the 
resultant extremity compartment syndrome. The PIV was also discontinued, and a new cath-
eter is placed in the contralateral hand. An emergency fasciotomy was performed, allowing 
salvage of the left hand and forearm, at the cost of a large left forearm scar. This substantially 
increased the length of stay and associated costs and reduced the patient’s hospital experi-
ence. Fortunately, there were no signs of ischemic injury or permanent nerve damage, and the 
patient had good functional recovery.
5. Overview of peripheral IV catheter complications
As outlined above, PIV catheters are routinely used for short-term delivery of intravascular 
fluids and medications, thus being among the most important and the most frequent invasive 
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procedure performed in hospitals. However, PIVs often fail before IVT is completed, with the 
cited malfunction rate of about 90% [2]. A prospective observational study, the CATHEVAL 
Project, suggested that the incidence of PVCAEs is significantly underestimated [1]. The inci-
dence rate of at least one PVCAE was 52.3%, with “clinical” PVCAEs occurring significantly 
more frequently than “mechanical” PVCAEs [1]. The most frequent clinical PVCAEs were 
phlebitis (20.1/100 PIVs), followed by hematoma (17.7/100 PIVs) and fluid/blood leakage 
(13.1/100 PIVs). In terms of mechanical complications, obstruction/occlusion of PIV was the 
most frequent event (12.4/100 PIVs) [1]. Of interest, the authors also reported on post-removal 
PVCAEs (21.7/100 PIVs) as well as infections (0.4/100 PIVs) [1]. Moreover, significant com-
plications can occur if the incorrect quantity (volume) of IV fluids or incorrect medication 
infusion/dosage is administered [45, 46].
The prevalence of difficult IV access can be substantial, with one study reporting 23% of patients 
classified as “moderately difficult” and 5% classified as having “difficult access” [47]. Of inter-
est, female gender and a previous history of several IV placement attempts may be associated 
with greater risk of difficult venous access, which in turn can increase the overall complication 
risk [48, 49]. Currently, there is no internationally accepted definition of a “difficult access” 
patient. Based on clinical observations many have tried to develop a predictive scale to identify 
adult patients with difficult intravenous access: the DIVA scale [50]. Such scales can be used to 
recognize patients with high probability of a difficult intravenous access. In such cases various 
assessment devices (near-infrared and ultrasound) or call for assistance of more experienced 
individuals in an earlier time frame can prove beneficial to the patient [41, 50].
Globally speaking, prevention of PVCAEs should be the preferred approach, and despite 
ongoing efforts to improve the current state of affairs, PVCAEs continue to occur, prompt-
ing the need for maintaining awareness and reinforcing provider education in this critical 
important area [18]. In a multicenter prospective study of 1498 patients by Cicolini et al. 
[51], the authors cited that anatomical site selection and a lack of adherence to in situ PIVC 
placement recommended guidelines resulted in increased rates of phlebitis. They concluded 
that additional staff education was needed [51]. DeVries et al. reported a 19% reduction in 
PIVC-associated bloodstream infections after implementing a fundamental PIVC insertion 
and education bundle for bedside nurses that increased staff awareness of proper skin prepa-
ration, aseptic technique, and the importance of the care and maintenance of dressings [52]. 
Nursing education leaders in another tertiary healthcare setting developed an educational 
intervention to improve the recognition and reporting of infiltration and phlebitis on medical-
surgical units, which was identified by the risk management database as a concern. Although 
the differences between pre- and post-knowledge scores were not significant (P = 0.21), the 
unexpected results of the research served as a catalyst to develop annual PIVC procedural 
education to validate competency related to PIVC-related complications [53].
A standardized approach to education and competency assessment across the healthcare 
system is recommended. A simulation-based multimodal educational method should be con-
sidered, including self-study and deliberate practice, with objective outcome monitoring and 
feedback using well-designed, validated, and reliable checklists [36, 54–56]. After all, it is the 
responsibility of the entire healthcare team to monitor for signs and symptoms of PVCAEs 
and intervene in a timely and appropriate fashion [30].
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Subsequent paragraphs of this chapter will discuss PVCAEs grouped into “localized” or “sys-
temic” categories.
6. Local PVCAEs
Phlebitis: Phlebitis is an inflammation of the vein and causes pain, swelling, redness, and ten-
derness. It can be caused by various sources like mechanical, chemical, or infective insults to 
the vein [2]. The mechanical cause; irritation with cannula rubbing the vein, chemical cause; 
medications with a hypertonic or acidic/alkaline solution, or an infective phlebitis; microor-
ganism entering the vein through the puncture site can cause the inflammation [30]. Diagnosis: 
It is one of the most talked about complication in the literature [2]. The diagnosis of superficial 
phlebitis can be made by physical examination of the site. Redness, warmth, tenderness, and 
swelling along the course of the vein can help make the diagnosis, although there are more 
than 70 tools used in the literature and none well validated [57]. In certain cases, an ultra-
sound of the affected area is needed to make or ignore the diagnosis. Prevention and treatment: 
Most complications are preventable if simple hand hygiene and safe principles are observed 
at every point of contact with the patient [2]. According to a recent secondary analysis, the 
antecubital fossa is associated with lower phlebitis rates as compared with upper arm and 
wrist veins [37]. Another systemic review showed that the antecubital veins had lower rate of 
phlebitis as compared to hand veins [58]. The treatment of phlebitis depends on the location, 
extent, symptom, and underlying medical conditions. Typically, it should be removed and 
documented with the time, date, and reason of removal [59]. Documentation can improve 
the staff compliance and help to improve quality of care of the patients with PIVC [60, 61]. 
Superficial phlebitis can be treated by applying warm compresses, elevation of the involved 
extremity, and oral or topical anti-inflammatory medications. External compression with fit-
ted stockings may be beneficial for lower extremity superficial phlebitis. If left untreated, 
superficial phlebitis can complicate to local infection and abscess formation, clot formation, 
and progression to a deep venous thrombosis and pulmonary embolism. Deep vein thrombo-
sis can further lead to postphlebitic syndrome.
Tissue infiltration and extravasation: Tissue infiltration occurs when the infusate solution is inad-
vertently administered (or leaks out) into the surrounding tissues. It can be caused by improper 
placement, dislodgement, or distal puncture/erosion of the catheter and can be associated with 
relative movement of the patient and the catheter. Extravasation arises when a solution or 
medication is administered and inadvertently leaks into the surrounding tissues, causing tissue 
damage. This unintended leakage can be caused by the same reasons as infiltration, including 
improper placement or dislodgement of the catheter. Certain sites are more prone to extravasa-
tion injuries like dorsum of the foot, ankle, antecubital fossa, and the areas near joints where 
there is little protection for underlying structures [18]. Of interest, extravasations tend to be 
more common during night hours and thus may be more likely to go undetected, even in closely 
monitored situations. Extravasation is more likely to occur in patients with fragile, mobile, 
thrombosed, and difficult to cannulate veins [18]. The degree of subsequent cellular injury is 
determined by the volume of the infiltrating solution and physiochemical characteristics, such 
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as pH, osmolarity, and dissociability [18]. Diagnosis: The diagnosis of infiltration is usually made 
by observing local tissue edema, cool skin with blanching, and decreased (or stopped) flow rate. 
The patient usually complains of discomfort, burning, and tightness of the involved extremity/
anatomic location [62]. Comparison to the contralateral limb may help confirm this diagno-
sis. In the case of extravasation, signs and symptoms may be similar to infiltration but will 
additionally include burning, irritation, redness, blistering, mottling, ulceration, or permanent 
damage like necrosis of the affected tissue. The damage can spread to involve nerves, tendons, 
and joints even months after the original insult [18]. It can additionally include disfigurement, 
complex regional pain syndrome, and loss of function [63]. Prevention and treatment: Prevention 
of infiltration includes the avoidance of PIV placement in the hand, antecubital fossa, and upper 
arm, properly securing the catheter and monitoring the IV site frequently [2, 36]. It is important 
to check the patient’s pulse and capillary refill [64]. Clinical management includes stopping 
the infusion, removing the PIV, elevating the limb, and general measures to alleviate patient 
discomfort. It has also been reported that local application of hyaluronidase may help, primarily 
through breaking down subcutaneous cellular components and speeding up the reabsorption 
of the extravasated fluids [65, 66]. Finally, the original infusion should be restarted at a different 
site, with all pertinent interventions documented in the medical record.
Prevention of extravasation includes careful placement of PIV cannula, close monitoring of 
active intravenous fluid infusions, flushing the catheter with sterile saline to ensure patency, 
and the use of suitable dressings and securements to prevent undue movement [18]. Once 
extravasation is recognized, the infusion needs to be stopped and the cannula removed. This 
is especially important when the medication/fluid being infused is potentially toxic to local 
tissues. Palpable effusion in the subcutaneous tissues may need to be drained, and the limb 
should be immobilized and elevated above the level of the heart. Application of cold packs 
can provide symptomatic relief. Indications for surgery include full-thickness skin necrosis, 
ulceration, and persistent pain [67]. If appropriate treatment is delayed, surgical debridement, 
skin grafting, and amputation may be the end result of such an injury [18].
Hemorrhage/hematoma: Hemorrhage is defined as bleeding from the puncture site, while hema-
toma is a localized collection of extravasated blood, usually clotted, within an organ or tissue. 
Both hemorrhage and hematoma may be caused by blood leaking out of the vein into the tissue 
due to puncture or trauma. The COSMOS study found that PIV catheters based on a compact 
closed system were associated with lower rate of hematomas when compared to a mounted 
open system [68]. Patients who receive antiplatelet therapy or therapeutic anticoagulation 
are especially predisposed to hematoma/ecchymosis formation [69]. Diagnosis: The signs and 
symptoms of swelling, tenderness, and reddish discoloration at the site are usually sufficient 
to diagnose PIV-related hematoma. Prevention and treatment: The first management step is the 
application of appropriate localized pressure until the bleeding stops. This is followed by a 
sterile transparent dressing that can prevent hematoma formation or expansion. Proper PIV 
insertion, frequent monitoring of the site, and application of pressure after removal of cannula 
can help prevent hemorrhage and formation of hematoma. At the same time, patients, provid-
ers, and nurses should be mindful of using extended external compression times at the insertion 
site, especially in older patients with impaired skin conditions, as this can lead to further tissue 
injury [1]. The majority of PIV-related bleeding and hematomas are fortunately self-limited.
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Nerve injury: When tissue infiltration associated with a PIV catheter affects a nerve coursing 
the surrounding tissues, nerve injury can occur. It is also possible for the IV needle to lacerate, 
puncture, and potentially injure a nerve. Finally, localized bleeding/hematoma may irritate a 
nerve. Diagnosis: Patients may not experience any discomfort in the beginning, but it is pos-
sible for localized numbness or tingling, loss of sensation to pin prick to emerge later on [70, 
71]. Nerve injury can range from neurapraxia with complete recovery (minor injury) to neu-
rotmesis with Wallerian degeneration distal to the site of injury (severe injury) [70]. Prevention 
and treatment: The avoidance of nerve injury requires good procedural skills and knowledge 
of pertinent anatomy. The PIV placing provider should be conscious of venipuncture sites 
associated with the greatest risk, including the distal sensory branches of the radial and ulnar 
nerves for sites in the dorsal hand, the superficial radial nerve at the cephalic vein of the radial 
wrist, the median nerve on the volar aspects of the wrist, the median and anterior interosse-
ous nerves at or above the antecubital fossa, and the lateral and medial antebrachial nerves for 
the antecubital fossa [36]. The needle insertion should be as shallow as possible, preferably at 
an angle of 5–15° relative to the skin and using the non-dominant arm [71]. Although nerve 
injury is rare, the patient should still be aware of this complication and encouraged to inform 
the nurse immediately if he or she experiences any strange sensation during PIV placement. 
Nerve damage tends to be self-limited, with typical recovery times of a few weeks or months. 
Surgical exploration may be required in patients with intractable pain, severe functional loss, 
or those without recovery signs within 3–6 months after the initial injury [72–74].
Occlusion: Occlusion is defined as the slowing or cessation of fluid infusion. It can occur due 
to the mechanical blockage within the cannula or fibrin deposition in/around the tip of the 
cannula. In addition, it may be due to swollen phlebitic veins, or insertion at a point of flex-
ion, both of which may collapse the catheter and prevent flow [75]. There may be a higher 
incidence of occlusion associated with insertion in the hand, antecubital fossa, or upper arm, 
when compared to forearm placement [2, 37]. 25.6% had failed catheterization due to PIV 
occlusions in an analysis from a randomized controlled trial in Australia. The occlusion was 
associated with infusions of antibiotics, hydrocortisone, in the setting of concurrent infection, 
and the use of subsequent (rather than initial) catheters [37]. In a single-center prospective 
study done in Australia, catheter failure due to occlusion/infiltration was reported to be 14%. 
In the same study, flucloxacillin, female gender, and 22-gauge PIVs were significant predic-
tors of occlusion [49]. Diagnosis: Occlusion can be diagnosed by the presence of discomfort, 
blood within the line, or PIV not running. Prevention and treatment: Actively checking for kinks 
and removing nonfunctioning cannulas will help reduce the overall duration of functional 
occlusion. Insertion of PIV by a trained specialist may also help reduce the risk of occlusion 
[37]. Various methods have been tried to prevent occlusion. In recent randomized trial, the 
rate of occlusion was lower with heparin infusion compared to placebo infusion [59].
Dislodgement: Dislodgement can occur when IV catheter was incorrectly secured with stan-
dard medical tape or another adhesive securement device. More frequently, catheters that 
are correctly secured become dislocated when more forces are applied upon the catheter than 
the securement method was intended to endure. IV dislodgement can lead to an unscheduled 
IV restart or more invasive central line. Dislodgement rate has been reported in the range of 
3.7–9.9% in a prospective randomized study with a mean of 6.9%. Even a greater rate of 17.5% 
Vignettes in Patient Safety - Volume 4122
was observed in prospective observational studies [2]. At almost 10% dislodgement rate, 
financial dislodgement burden can be tremendous translating to 33 million, if approximately 
330 million IV catheters are sold in the USA [76]. Diagnosis: Cannula location is estimated by 
the flow of IV fluids and/or IV flushes. To evaluate PIVC fiction or dislodgement, we need to 
ask questions like does the IV flush easily and does the IV fluid flow easily? Prevention and 
treatment: Transparent and semipermeable polyurethane or sterile gauze and tape dressing 
are both recommended [77, 78]. Catheters with stabilization features like wings may help 
to secure the catheter due of an additional adhesive dressing contact area [79]. To decrease 
catheter movement and increase the adhesive surface area, attaching extension tubing to the 
catheter hub may prove beneficial [80]. Effective securement reduces the motion within the 
vessel which can in turn minimize the irritation, inflammation, occlusion, and risk of infec-
tion [77, 81]. At the same time, increase in catheter complex bulk may make the catheter more 
vulnerable to displacement due to clothing grabbing onto the catheter complex [38].
Venous spasm: Venous spasm is a complication of various minor procedures, including PIV 
insertion and arterial line placement [82]. Venous spasm can occur in the presence of cold 
IV fluid infusion, drug-related irritation, or trauma to the vein during insertion [82–84]. 
Diagnosis: The signs and symptoms of pain, blanching at the insertion site, slowing of IV 
infusion, and difficulty in palpating the vein can help facilitate the diagnosis. Prevention and 
treatment: Applying a warm compress, slowing the infusion rate, and potential application of 
a topical vasodilator, in addition to patient reassurance [82, 85] See Table 1.
7. Systemic complications
Air embolism: Air embolism is defined as an unintended venous administration of air through 
an intravenous access device or insertion site. It is usually associated with central venous 
catheters but can also occur with peripheral intravenous central catheters and less commonly 
with short peripheral catheters. The incidence of this complication may be low, but it is poten-
tially fatal, with reported mortality as high as 30% [86]. Clinical signs and symptoms may 
vary depending on the patient, rate of infusion, volume of air, and anatomical location [87]. 
Physiologic injury can be due to associated ischemia, infarction, thrombotic, or inflammatory 
response. Diagnosis: Clinical signs and symptoms of air embolism may be nonspecific and not 
readily recognizable, yet immediate intervention is critical to adequately address the problem 
and prevent/minimize associated harm. Patient may present with sudden onset of dyspnea, 
cough, wheezing, chest or shoulder pain, tachypnea, tachycardia, hypotension, and/or neuro-
logical findings of cerebrovascular accidents [86, 88]. Prevention and treatment: For peripherally 
inserted catheters, prevention includes the avoidance of air, both primarily and by so-called 
“air traps” built into the IV circuit. When placing and removing central venous catheters, the 
patient should be placed in Trendelenburg (during catheter removal), followed by supine 
(subsequent 20–30 min) position. Prompt diagnosis and focused treatment are mandatory in 
cases of air embolism. After stabilizing the patient, immediate evaluation and management 
should be instituted [89]. Affected patients should be transferred to intensive care for close 
monitoring, with considerations given to hyperbaric oxygen therapy as an adjunct [88].
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Pulmonary edema: Pulmonary edema or fluid overload is caused by excess fluid accumula-
tion in the lungs, due to excessive fluid in the circulatory system [90]. Elderly, pregnant 
women, children, infants, and patients with cardiac, pulmonary, or renal disease are at 
risk of developing hypervolemia. In the context of IVT, fluid overload usually represents 
a combination of errors, from miscalculated IV rate, to inadvertently prolonged infusion, 
to lack of diagnostic recognition of early clinical symptoms. Diagnosis: Patients usually 
present with restlessness, breathlessness, tachycardia, dyspnea, cyanosis, and pink frothy 
sputum. Chest radiography can show typical findings of cephalization, interstitial edema, 
pulmonary vein enlargement, hilar fullness, Kerley lines, cardiomegaly, and pleural effu-
sion [91]. Associated findings may include decreased oxygen saturation, increased respira-
tory rate, and pulmonary crackles on auscultation. Finally, increased body weight (e.g., 
“water weight”) may be noted [92]. Prevention and treatment: The diagnosis of acute fluid 
overload requires immediate medical attention and treatment. This involves stopping the 
infusion, raising the head of the bed, applying oxygen, taking vital signs, complete cardio-
vascular assessment, diuresis when indicated, and appropriate education of the involved 
medical providers.
Catheter fragment embolism: Intravascular embolization of catheter fragment is a rare com-
plication that occurs when a small part of the cannula breaks off and flows into the vascular 
system [93, 94]. Diagnosis: Symptomatology and diagnostic identification of intravascular 
embolization of catheter fragments are variable, largely depending on the location and 
size of the object. Most events are completely asymptomatic and only found incidentally 
on imaging performed for unrelated reasons [94]. Larger fragments, especially those that 
migrate into more central venous and pulmonary circulation, may result in palpitations, 
arrhythmias, chest pain, shortness of breath, cough, pain, and/or hypotension [86]. Chest 
X-rays may help assess the presence of any fragment. Prevention and treatment: Prevention 
starts with a careful inspection of the cannula and more specifically its distal end, to see if 
the PIV is structurally intact. Catheters should not be removed against unexpected resis-
tance, which should prompt further investigation (e.g., ultrasound) before proceeding. PIV 
devices should be protected from twisting, bending, entanglement, etc. Repairs should 
only be done through official channels involving the manufacturer. Each event should 
be documented and disclosed to patients and their families, in accordance with existing 
guidelines [86].
Infection: Local infection is caused by lack of asepsis at insertion or regrowth of skin bacte-
ria which then enter the PIV site. It can present as purulent drainage from the site; usually 
after 2–3 days it takes the body to mount a response after PIV placement. The majority 
of serious bloodstream infections are associated with central venous catheters, especially 
when catheters are placed emergently or used for prolonged periods of time [59]. For PIV 
catheters, the situation is different, since these are placed in less acutely unwell patients 
and typically require shorter periods of hospitalization and IVT. Although bacterial coloni-
zation of PIV catheters can increase with dwelling times of more than 72 h, there does not 
seem to be an elevated risk of associated phlebitis or infection regardless of whether the 
PIC catheter is replaced due to clinical indication or subject to routine replacement between 
72 and 96 h [1, 2, 95, 96]. Thus, international guidelines now recommend removal of PIVCs 
when treatment is completed or sooner if any complication develops [97, 98]. Despite the 
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Peripheral venous catheter adverse events
(PVCAEs)
Local complications Systemic complications
Tissue infiltration and extravasation
Infusate solution leaks out into the surrounding tissue
Diagnosis: detecting local tissue edema, cool skin, 
decreased flow rate, and comparison with contralateral 
limb
Prevention: avoiding PIV too close to the joint, securing 
the catheter, and monitoring site frequently
Air embolism
Rare unintended venous administration of air through IV site
Diagnosis: nonspecific sudden onset of dyspnea, cough, 
wheezing, tachypnea, and/or neurological signs of CVAs
Prevention: avoidance of air-traps in IV circuit; patient is in 
Trendelenburg position followed by supine position during 
catheter removal
Hemorrhage/hematoma
Bleeding from puncture site/localized collection of 
extravasated blood
Diagnosis: swelling, tenderness, and reddish 
discoloration
Prevention: application of pressure after removal of 
cannula, usage of sterile transparent dressing
Pulmonary edema
Fluid overload caused by excess fluid accumulation in the lungs
Diagnosis: breathlessness, tachycardia, dyspnea, cyanosis, pink 
frothy sputum, chest radiography, decreased oxygen saturation
Prevention: avoidance of miscalculation IV rate and prolonged 
infusion, early recognition of symptoms
Nerve injury
Due to tissue infiltration, IV needle laceration, 
hematoma irritation
Diagnosis: localized numbness or tingling, loss of 
sensation to pin prick
Prevention: good knowledge of anatomy, shallow 
insertion at 5–15 degrees relative to the skin
Catheter fragment embolism
Small part of the cannula breaks off and flows into the vascular 
system
Diagnosis: symptomatology depends on the location,  
incidental finding on imaging, chest X-ray
Prevention: careful inspection of cannula; catheters should  
not be removed against unexpected resistance; repairs  
should only be done by manufacturer
Occlusion
Slowing or cessation of fluid infusion
Diagnosis: presence of discomfort, blood within the PV 
line, PIV not running
Prevention: check the kinks; remove the nonfunctioning 
cannula
Infection
Purulent discharge from the site after 2–3 days
Diagnosis: presence of purulent discharge, and/or temperature, 
blood count, D-dimer
Prevention: hand hygiene, aseptic technique
Dislodgement
Due to more forces applied upon the catheter than the 
securement method was intended to endure
Diagnosis: checking the flow of IV fluids or IV flushes
Prevention: effective securement; use of catheters with 
wings, extension tubing for movement
Hypersensitivity
A severe hypersensitivity can be life- threatening
Diagnosis: sudden fever, joint swelling, rash, urticarial, 
bronchospasm, wheezing
Prevention: ask about any previous history of allergies, stay 
with the patient for five to ten minutes to detect early signs
Venous spasm
Due to cold IV fluid infusion, drug-related irritation, or 
trauma to the vein
Diagnosis: pain, blanching at the site, difficulty in 
palpating vein
Prevention: apply warm compress; slow infusion rate
Intra-arterial placement
Misplacement of PIV due to lack of vigilance
Diagnosis: detection of pulsatile blood, changes in capillary 
refill, appearance of ischemia, blood gas analysis, ultrasound
Prevention: recollecting that veins are more superficial than 
arteries, immediate removal of PIV after detecting pulsatile 
bleeding
Table 1. Local and systemic complications of peripheral venous catheter.
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low occurrence of both local and bloodstream infections involving PIV catheters, severe 
infections can still significantly contribute to patient morbidity simply because of the ubiq-
uitous nature of peripheral catheters [59]. Diagnosis: Local infection can be diagnosed by 
signs and symptoms of tenderness, swelling, erythema, purulent drainage, temperature, 
and appropriate laboratory testing (e.g., comprehensive blood count or D-dimer in cases 
of phlebitis) [99]. Of note, lower extremity PIVs are associated with higher incidence of 
infections when compared to upper extremity PIVs [100]. Prevention and treatment: To 
reduce morbidity and financial burden of PIV-related infections, appropriate education 
and multidisciplinary efforts should be implemented. For all PIV catheters, a clean, dry, 
intact dressing is recommended because any soilage will facilitate microorganism growth. 
Any soilage covered by nontransparent dressings can increase the risk of not detecting 
infection [1]. The density of skin flora at the site plays an important role in infection. From 
purely procedural perspective, the first and essential parts of the process should involve 
removal of the infected PIV cannula and cleansing of the site using sterile technique. Hand 
hygiene, clipping of excess hair, skin preparation with alcoholic chlorhexidine solution, 
proper aseptic technique, and maximal sterile barriers including cap, mask, sterile gown, 
and gloves during insertion can reduce the incidence of infection [59]. During the PIV 
insertion process, the antiseptic scrubbing technique also modulates the risk of infection 
[76]. Post-insertion, infection prevention is still crucial and is achieved by meticulous atten-
tion to hand hygiene, aseptic preparation of injectates and infusates, needleless connec-
tor decontamination with effective antiseptic, and technique. The insertion site requires 
weekly redressing (or sooner if the dressing is compromised), including recleaning of the 
insertion site with alcoholic chlorhexidine. Under certain circumstances, such as neutrope-
nic patients, filling and flushing the lumen of the catheter with an antibiotic solution may 
provide some prophylactic benefits [59]. A final and very simple way to prevent PIVC-
associated infections is to ensure the PIVC is reviewed daily and documented, and there is 
consideration of removal, for example, with the patient moved to oral medication [101] and 
vigilance for “idle PIVCs” See Table 1.
8. Special topics
Intra-arterial placement and injection: An intra-arterial misplacement of PIV, including the ini-
tiation of intra-arterial infusion, occurs seldom but is considered a matter of serious concern. 
Although the precise number of inadvertent intra-arterial PIV cannulation and subsequent 
injection is unknown, the frequency has been estimated to be as low as 1 in 56,000 and as 
high as 1 in 3440 [102]. However, the potential consequences of missing the diagnosis can 
be devastating. If not promptly recognized, its consequences may include arterial spasm, 
distal ischemia, and eventual development of limb-threatening gangrene [103]. Risk factors 
associated with unintentional arterial PIV placement include morbid obesity, dark skin, lack 
of patient cooperation, significant hypotension, and lack of vigilance [103, 104]. Diagnosis: 
Diagnosis can be made by detecting red pulsatile blood, observing changes in capillary refill, 
the presence of intense pain, and/or the appearance of distal ischemia. Confirmation is done 
by blood gas analysis, pressure transducer placement, and ultrasound [104]. Prevention and 
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treatment: Prevention is the most important measure in this setting. Providers must take great 
care that the PIV catheter is inserted into a vein, remembering that peripheral veins tend to 
be more superficial than arteries. Except for very few clinical circumstances (e.g., catastrophic 
hypotension), arterial cannulation will result in readily visible, pulsatile bleeding from the 
PIV catheter. In the case of inadvertent intra-arterial injection, it is primarily the intravenous 
drug that will be most likely to contribute to subsequent problems, as opposed to the ordinary 
intravenous electrolyte solution. Management consists of PIV catheter removal, assurance of 
hemostasis, prevention/management of vasospasm, and treatment of any distal complications 
See Table 1.
Forgotten tourniquet: Phlebotomy tourniquets are simple devices used to temporarily restrict 
venous blood flow, making veins more prominent and easier to see prior to PIV catheter 
placement. Some considerations regarding the use of tourniquets include the need for 
optimized location of placement (3–4 inches above intended PIV site), avoiding too much 
tension to prevent tourniquet from rolling up on itself/twisting and causing discomfort 
and releasing the tension within approximately 1 min of application [105]. Fortunately a 
rare occurrence, a phlebotomy tourniquet left in place for prolonged periods of time (e.g., 
hours) can result in the development of extremity compartment syndrome—a potentially 
limb-threatening condition [106, 107]. Compartment syndrome is a serious injury defined 
by an increase in pressure within a fascia-enclosed muscle compartment that results in 
compromised circulation leading to nerve damage and muscle necrosis [108]. This can lead 
to permanent disability, amputation, or even death from the release of toxic metabolites. 
Many of the above findings may not be present until late in the disease process. Thus, early 
diagnosis is imperative [109, 110]. A high degree of suspicion is crucial to allow an early 
diagnosis. Pain requiring analgesia in the extremity with the PIV should raise awareness 
and prompt a thorough examination of the entire extremity. Diagnosis can be especially 
challenging in children, intubated and sedated patients, and patients with neurological 
compromise or altered mental status. Increased vigilance must occur in these patients. If 
compartment syndrome is suspected once a “forgotten tourniquet” event occurs, an urgent 
surgical consult should be obtained. To prevent this serious omission and thus improve PS, 
appropriate education/training and procedural checklist implementation may be helpful 
[111]. Such occurrences, due to the potential for associated patient harm, should be viewed 
and treated as sentinel events [112]. In addition to compartment syndrome, this complica-
tion can also lead to the development of deep vein thrombosis in the affected limb [107]. 
This chapter’s Clinical Vignette was based on a hypothetical scenario involving this rare but 
potentially severe occurrence.
9. Discussion
Due to its ubiquitous nature, IVT is associated with significant number of complications, 
both in terms of absolute quantity and taxonomy. In a recent survey, approximately one-
third of pediatric patients and one-fourth of adult patients reported experiences involving a 
potentially preventable IVT-related complication. As outlined throughout this book series, 
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patient safety is a “team sport” [111, 112]. Consequently, active participation of all stakehold-
ers is required to optimize patient outcomes. This involves active involvement of all those 
who directly or indirectly participate in IVT—providers, patients, and families. Our Clinical 
Vignette demonstrates the dangers inherently associated with increasingly complex systems, 
where transitions of care occur frequently and where several different teams care for the same 
patient over a period of just several hours. In such environments, even the smallest mistake 
can result in catastrophic sequelae.
In this chapter, we outlined key considerations around two primary types of PVCAEs—local 
and systemic. We also discussed intra-arterial PIV catheter placement and the rare but dev-
astating scenario involving the “forgotten tourniquet.” Each topic was presented in a clini-
cally relevant fashion, incorporating a brief description, diagnosis, management, and finally 
prevention. Clinical approach to preventing PVCAEs is multipronged and includes a broad 
variety of considerations, such as checklists, knowledge of procedures and equipment, proper 
sterile technique, and the maintenance of appropriate PIV site cleanliness. Providers must 
also be aware of subtle clinical signs of PVCAEs, including PIV site erythema, IVT-related 
tissue injury, manifestations of air embolization, and signs of PIV catheter occlusion [2, 113]. 
In addition, each of the sections outlined specific strategies to prevent PVCAEs and PIV 
catheter failure. With growing numbers of patients needing vascular access for a range IVTs, 
providers need to show an understanding of the broad range of vascular access devices and 
corresponding clinical management aspects, including specific indications for various device 
types. Finally, providers need to be aware of patient needs, preferences, and concerns. After 
all, for many patients it is not the procedure that is of maximum concern but rather the clini-
cian’s communication skills, competence, and appropriate selection of PIV insertion site [114]. 
Patients and their families may be greatly untapped allies in preventing, monitoring, and 
reporting adverse events [101].
10. Conclusion
In summary, PVCAEs continue to be quite common and can lead to substantial patient discom-
fort, unnecessary or prolonged hospitalization, increased costs, and additional downstream 
morbidity. To improve patient outcomes, enhance patient safety, and reduce healthcare costs, 
there has been a substantial interest to implement measures aimed at reducing the incidence 
of PVCAEs [2]. Efforts to prevent PVCAEs should involve thorough provider education, clini-
cal vigilance by all involved healthcare providers, as well as the proactive participation of all 
stakeholders, including patients and their families.
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